Modulating inflammation and neuroprotection in multiple sclerosis

Area of Science:

• Neuroimmunology
• Neurology
• Pathophysiology

Background:

• Multiple sclerosis (MS) is a central nervous system disorder with unpredictable progression.
• MS symptoms include sensory, motor, and cognitive impairments, impacting quality of life.
• While immunomodulation targets demyelination, gray matter involvement necessitates neuroprotection.

Purpose of the Study:

• To review MS pathophysiology and histopathology, focusing on neuroimmune interactions.
• To examine the role of oxidative stress and mitochondrial dysfunction in MS progression.
• To discuss current and emerging therapies for MS, emphasizing immunomodulatory and neuroprotective strategies.

Main Methods:

• Literature review of MS pathophysiology and histopathology.
• Analysis of neuroimmune interactions and their role in neurodegeneration.
• Evaluation of oxidative stress and mitochondrial dysfunction in MS.
• Review of current and pipeline disease-modifying therapies for MS.

Main Results:

• Neuroimmune interactions can drive neurodegeneration in MS through direct and indirect mechanisms.
• Oxidative stress and mitochondrial dysfunction are implicated in MS disease progression.
• Current therapies primarily focus on immunomodulation, with growing interest in neuroprotection.

Conclusions:

• Understanding neuroimmune interactions is crucial for developing effective MS treatments.
• Targeting oxidative stress and mitochondrial dysfunction may offer new therapeutic avenues for MS.
• Integrating immunomodulatory and neuroprotective approaches is essential for managing MS progression and disability.